Importantly, downregulation of DNASE1L3 was associated with poor patient survival for many cancer types (Supplemental Figure 1A; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.168161DS1), including CRC (Figure 1B). This evidence concerns the gene DNASE1L3 and colorectal carcinoma.